"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Bishal Gyawali: In this perspective piece out in NEJM today, we discuss finding the right balance for accelerated approval of cancer drugs in the context of the recently proposed FDA guidance.
Inimfon Jackson: I’m honored to be invited to serve as a member of the ASCO Trainee and Early Career Advisory Group
Linvoseltamab (Lynozyfic) 2025 Updates: Uses in Cancer, Dosage, Side Effects, Expectations, and More
Meet the ACCELERATE Working Group on Fostering Age Inclusive Research - SIOPE
Runcie Chidebe: Privileged to meet Professor Emeritus Ian F. Tannock
Ruben Mesa: Off to the races with Lung Cancer debates at Carolina Cancer Confab
